Share on StockTwits

Equities researchers at Stifel initiated coverage on shares of Medidata Solutions (NASDAQ:MDSO) in a research report issued on Tuesday. The firm set a “buy” rating and a $47.00 price target on the stock. Stifel’s price target points to a potential upside of 18.39% from the company’s current price.

Other equities research analysts have also recently issued reports about the stock. Analysts at Stifel Nicolaus initiated coverage on shares of Medidata Solutions in a research note on Tuesday. They set a “buy” rating on the stock. Separately, analysts at Topeka Capital Markets initiated coverage on shares of Medidata Solutions in a research note on Friday. They set a “buy” rating and a $48.00 price target on the stock. Finally, analysts at Ned Davis Research upgraded shares of Medidata Solutions from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $57.28.

Shares of Medidata Solutions (NASDAQ:MDSO) opened at 39.70 on Tuesday. Medidata Solutions has a one year low of $32.10 and a one year high of $68.21. The stock has a 50-day moving average of $37.62 and a 200-day moving average of $53.03. The company has a market cap of $2.076 billion and a price-to-earnings ratio of 223.77.

Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Tuesday, April 22nd. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by $0.05. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $79.50 million. During the same quarter in the previous year, the company posted $0.18 earnings per share. The company’s revenue for the quarter was up 21.0% on a year-over-year basis. Analysts expect that Medidata Solutions will post $0.75 EPS for the current fiscal year.

Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.